Company
Ollin Biosciences, Inc.
| Industry | clinical-stage biotech advancing therapies for vision-threatening diseases |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Ollin Biosciences, Inc. | Series B | 2026-06-24 |
Company
| Industry | clinical-stage biotech advancing therapies for vision-threatening diseases |
|---|
| Company | Round | Date |
|---|---|---|
| Ollin Biosciences, Inc. | Series B | 2026-06-24 |